Anavex Life Profile

4.42
USD 0.42  8.68%
4.02Last Month High 4.84 
4.22Trading Day  High 4.45 

Purchase by Christopher Missling of 375 shares of Anavex Life

Anavex Life Sciences Corp insider trading alert for perchase of common stock by Christopher Missling, President and CEO, on October 18, 2017. This event was filed by Anavex Life Sciences Corp with SEC on 2017-10-18. Statement of changes in beneficial ownership - SEC Form 4. Christopher Missling is currently serves as president ceo, cfo, treasurer, secretary, director of Anavex Life Sciences [view details]   

Anavex Life Summary

Anavex Life Sciences Corp (AVXL) is traded on Nasdaq Capital Markets in USA. It is located in NEW YORK, U.S.A and employs 10 people. Anavex Life is listed under Business Services category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 184.29 M. Anavex Life Sciences Corp has 42.17 M outstanding shares of which 5.19 M shares are presently shorted by private and institutional investors with about 13.63 trading days to cover. ANAVEX LIFE SCIEN currently holds about 24.79 M in cash with (8.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.59.
Check Anavex Life Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Edge Wealth Management LlcCommon Shares50 K209 K
Cutler Group LpCommon Shares17.5 K72 K
Cutler Group LpPut Options44.3 K41 K
Cutler Group LpCall Options26.2 K15 K
View Anavex Life Diagnostics

Selected Anavex Life Sciences Corp Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Anavex Life Against Markets

Current Ratings  

Anavex Life 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
12 
Chance of
< 78% 
Anavex Life Sciences Corporation, a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of Alzheimers disease, other central nervous system diseases, pain, and various cancers. more
Fama & French Business Services
Business Services
Fama & French Classification
NameAnavex Life Sciences Corp
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationNEW YORK, U.S.A
Business AddressNew York, NY
ExchangeNasdaq Capital Markets
CIK Number01314052.0
CUSIP032797300
IndustryBusiness Services
BenchmarkDOW
Websitewww.anavex.com
Contact Number844 689 3939
CurrencyUSD - US Dollar

Recommendations

Anavex Life Analyst Recommendations
Target PriceAdvice# of Analysts
13.67Strong Buy3Odds
Anavex Life Sciences Corp current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Anavex Life Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas